We noticed that the predictive capacity of SLC10A3 was the highest among recurrent tumor population, most likely to the fact that they exhibited the higher expression of SLC10A3, and up-regulation of SLC10A3 correlating well with the immune check points. This evidence concerns the gene SLC10A3 and neoplasm.